First Hematopathology Update held at FMRI
Gurugram: Successful management of patients with hematologic malignancies depends upon accurate and timely diagnosis, which frequently requires integration and interpretation of multiple tests like morphologic examination of peripheral blood, bone marrow aspirate, and bone marrow biopsy specimens.
In a country where 80% of cancers are detected only at Stage 4, accurate and timely diagnosis is critical for a positive outcome.
Fortis and SRL are committed to this, and keeping the commitment SRL in collaboration with Dr Rahul Bhargava, Director, Institute of Blood disorders, Fortis Memorial Research Institute, Gurugram, conducted the first 'Hematopathology Update and Workshop' at FMRI on Fortis and SRL on April 27th, 2019,
While speaking to Medical Dialogues Dr. Rahul Bhargava told "Hematopathology is a new branch. As we are progressing morphology still remains the gateway for early and correct diagnosis. This meeting was a beginning of series to develop expertise in morphology and helping the country with early diagnosis". "1849 Virchow has said think microscopically and 2019 we have give a new mantra think morphologically in today’s era" he adds.
The program essentially focuses on the importance of these diagnostic modalities for early diagnosis and better patient outcomes.
It was inaugurated by Mr Arindam Halder, CEO of SRL, along with Dr B. Keshav Rao, Head MOG, Fortis Healthcare. They were accompanied by Dr Ritu Garg, Zonal Director FMRI, Dr Abha Sabhikhi, Technical Director, SRL CoE & SRL Fortis Labs, Dr Aarti Gupta, Dr Ajay Dogra, Dr Rajeev Nayyar, Dr Sachin Jain and Dr Sanjeev Gupta from AIIMS.
The response was overwhelming - with Pathologists from Delhi NCR, Rohtak, Aligarh, Mumbai and Bengaluru attending the event. The Program had attendees from the government as well as Private Medical Colleges too.
The Faculty included stalwarts from AIIMS, Fortis and SRL.
Hands-on training of peripheral smear and bone marrow slides was conducted and it was gratifying to see over 40 delegates come together to share best practices in haematopathology and brainstorm the way forward, with the vision of serving the people of this country better.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.